What is Poliomyelitis Vaccine Market Scope?
Poliomyelitis is a highly infectious viral disease caused by poliovirus that invades the human nervous system, causing severe life-threatening disability and irreversible paralysis. Poliomyelitis is considered an acute communicable disease caused by human enteroviruses of the Picornaviridae family. Polioviruses may spread by stool-to-mouth or mouth-to-mouth routes due to poor hygiene and personal hygiene. Polio vaccines like the oral polio vaccine (OPV) and the inactivated poliomyelitis vaccine (IPV) are being developed to immunize children against polio. The OPV contains attenuated live strains of such viruses and the IPV contains three poliovirus strains, Mahoney Type 1, MEF-1 (Middle East Forces) Type 2, and Saukett Type 3. OPV is given by the oral route while the IPV is given by the injectable route. It can be prevented by the polio vaccine.
The Poliomyelitis Vaccine market study is being classified by Type (Oral Polio Vaccine (OPV) and Inactivated Poliomyelitis Vaccine (IPV)), by Application (Hospital, Clinics, Public Services and Others) and major geographies with country level break-up.
There are relatively a few vaccine manufacturers that meet the international standards, due to which an individual vaccine manufacturer, the market becomes monopolies or oligopoly either by the means of product or presentation. Very, few suppliers and production capacities lead to a tenuous balance between demand and supply in many individual vaccine markets. Research Analyst at AMA predicts that Players from Asian will contribute to the maximum growth of Global Poliomyelitis Vaccine market throughout the predicted period.
Sanofi (France), GSK (United Kingdom), Bibcol (India), Crucell (Johnson & Johnson) (Netherlands), Serum Institute (India), Merck & Co. (United States), Tiantan Biological (China), Panacea Biotec Ltd. (India), Bio-Med (India), Halfkin Bio-Pharmaceuticals Corporation Ltd. (India) and China National Biotech Group (China) are some of the key players profiled in the study.
Analyst at AMA have segmented the market study of Global Poliomyelitis Vaccine market by Type, Application and Region.
On the basis of geography, the market of Poliomyelitis Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
WHO ensures the safety and quality of vaccines and works closely on global standards which are developed and made readily available. WHO provides norms and standard and give advice to procurement agencies and countries on the acceptability, in the principle of vaccines. It has also established the Global Advisory Committee on vaccine safety which includes national experts and authority to support vaccine safety.
Influencing Market Trend
- A Rise in Rigorous Monitoring and Effective Communication
- Growth in Skilled and Motivated Staff, And Adequate Funding
- A Rise in Ensuring Vaccination in Conflict Zones and Countries with Weak Health Systems
- High Prevalence of Poliomyelitis
- The Increased Patient Awareness Level
- High Focus on Immunization Program around the Globe
- Increasing Efforts for Vaccination Led By the WHO and UNICEF
- Emerging Markets and Huge Investment in Research and Development
- High Prevalence of Poliomyelitis and Strong Immunization Programme by Government
- Complicated Regulatory Scenario
- High Cost Involved in Poliomyelitis Vaccine Development
Key Target AudienceNew Entrants/Investors, Analysts and Strategic Business Planners, Providers of Poliomyelitis Vaccine, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations and End-Use Industry
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.